USBC, Inc. — Director's Dealing 2020

Jan 24, 2020

SEC Form 4/A — Form 4/A

Issuer: KNOW LABS, INC. (KNWN)
CIK: 0001074828
Period of Report: 2020-01-01

Reporting Person: Bosua Phillip (Director, CEO and President, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-01	Common Stock	A	150000	$1.90	Acquired	3005000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock	$1.28	2023-08-01	Common Stock (1000000)	1000000	Direct
Option to Purchase Common Stock	$1.10	2024-11-04	Common Stock (1200000)	2200000	Direct

Footnotes

F1: Option shares vest 25% quarterly over four years beginning 08/01/2018.

F2: Option shares vest upon approval of the Company's blood glucose measurement technology by the U.S. Food and Drug Administration.